The popularity of Sildenafil initially drove a surge for the drug industry, but recent developments present a complicated picture for shareholders. Lower-cost alternatives are eating into revenue, and persistent patent https://rebeccayyur973790.yomoblog.com/48487928/viagra-and-the-pharmaceutical-industry-a-volatile-bet